Molecular Diagnostics in Cancer Testing Market Report

Global and Region Molecular Diagnostics in Cancer Testing Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：153
  • REPORT CODE：GMM1000874
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Molecular Diagnostics in Cancer Testing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Molecular Diagnostics in Cancer Testingmarket, defines the market attractiveness level of Molecular Diagnostics in Cancer Testing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Molecular Diagnostics in Cancer Testing industry, describes the types of Molecular Diagnostics in Cancer Testing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Molecular Diagnostics in Cancer Testing market and the development prospects and opportunities of Molecular Diagnostics in Cancer Testing industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Molecular Diagnostics in Cancer Testing market in Chapter 13.

    By Player:

    • LabCorp

    • bioMerieux

    • NSTG

    • Invitae

    • Genomictree

    • Exact Sciences Corporation

    • Counsyl

    • Epigenomics

    • bioTheranostics (AviaraDx)

    • Ambry Genetics

    • Flatiron Health

    • Genmark Diagnostics

    • Abbott Molecular Diagnostics

    • Neogenomics

    • Genoptix (Novartis)

    • Agendia

    • HTG Molecular Diagnostics

    • Biodesix

    • Nanostring

    • Accugenomics

    • Pathway Genomics

    • Orion Genomics

    • Myriad Genetics

    • Exiqon

    • Nuvera Biosciences

    • Genomic Health

    • Cancer Genetics

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • Application 1

    • Application 2

    • Application 3

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Molecular Diagnostics in Cancer Testing Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Molecular Diagnostics in Cancer Testing Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Molecular Diagnostics in Cancer Testing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Molecular Diagnostics in Cancer Testing Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Molecular Diagnostics in Cancer Testing Market Analysis and Outlook to 2022

    • 7.1 Global Molecular Diagnostics in Cancer Testing Consumption (2017-2022)

    • 7.2 United States Molecular Diagnostics in Cancer Testing Consumption (2017-2022)

    • 7.3 Europe Molecular Diagnostics in Cancer Testing Consumption (2017-2022)

    • 7.4 China Molecular Diagnostics in Cancer Testing Consumption (2017-2022)

    • 7.5 Japan Molecular Diagnostics in Cancer Testing Consumption (2017-2022)

    • 7.6 India Molecular Diagnostics in Cancer Testing Consumption (2017-2022)

    • 7.7 South Korea Molecular Diagnostics in Cancer Testing Consumption (2017-2022)

    8 Region and Country-wise Molecular Diagnostics in Cancer Testing Market Analysis and Outlook to 2028

    • 8.1 Global Molecular Diagnostics in Cancer Testing Consumption Forecast (2022-2028)

    • 8.2 United States Molecular Diagnostics in Cancer Testing Consumption Forecast (2022-2028)

    • 8.3 Europe Molecular Diagnostics in Cancer Testing Consumption Forecast (2022-2028)

    • 8.4 China Molecular Diagnostics in Cancer Testing Consumption Forecast (2022-2028)

    • 8.5 Japan Molecular Diagnostics in Cancer Testing Consumption Forecast (2022-2028)

    • 8.6 India Molecular Diagnostics in Cancer Testing Consumption Forecast (2022-2028)

    • 8.7 South Korea Molecular Diagnostics in Cancer Testing Consumption Forecast (2022-2028)

    9 Global Molecular Diagnostics in Cancer Testing Market Outlook by Types and Applications to 2022

    • 9.1 Global Molecular Diagnostics in Cancer Testing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Type 1 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Type 2 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Type 3 Consumption and Growth Rate (2017-2022)

    • 9.2 Global Molecular Diagnostics in Cancer Testing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Application 1 Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Application 2 Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Application 3 Consumption and Growth Rate (2017-2022)

    10 Global Molecular Diagnostics in Cancer Testing Market Outlook by Types and Applications to 2028

    • 10.1 Global Molecular Diagnostics in Cancer Testing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Type 1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Type 2 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Type 3 Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Molecular Diagnostics in Cancer Testing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Application 1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Application 2 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Application 3 Consumption Forecast and Growth Rate (2022-2028)

    11 Global Molecular Diagnostics in Cancer Testing Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Molecular Diagnostics in Cancer Testing Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Molecular Diagnostics in Cancer Testing Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Molecular Diagnostics in Cancer Testing Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Molecular Diagnostics in Cancer Testing Market Competitive Analysis

    • 14.1 LabCorp

      • 14.1.1 LabCorp Company Details

      • 14.1.2 LabCorp Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 LabCorp Molecular Diagnostics in Cancer Testing Product and Service

    • 14.2 bioMerieux

      • 14.2.1 bioMerieux Company Details

      • 14.2.2 bioMerieux Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 bioMerieux Molecular Diagnostics in Cancer Testing Product and Service

    • 14.3 NSTG

      • 14.3.1 NSTG Company Details

      • 14.3.2 NSTG Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 NSTG Molecular Diagnostics in Cancer Testing Product and Service

    • 14.4 Invitae

      • 14.4.1 Invitae Company Details

      • 14.4.2 Invitae Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Invitae Molecular Diagnostics in Cancer Testing Product and Service

    • 14.5 Genomictree

      • 14.5.1 Genomictree Company Details

      • 14.5.2 Genomictree Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Genomictree Molecular Diagnostics in Cancer Testing Product and Service

    • 14.6 Exact Sciences Corporation

      • 14.6.1 Exact Sciences Corporation Company Details

      • 14.6.2 Exact Sciences Corporation Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Exact Sciences Corporation Molecular Diagnostics in Cancer Testing Product and Service

    • 14.7 Counsyl

      • 14.7.1 Counsyl Company Details

      • 14.7.2 Counsyl Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Counsyl Molecular Diagnostics in Cancer Testing Product and Service

    • 14.8 Epigenomics

      • 14.8.1 Epigenomics Company Details

      • 14.8.2 Epigenomics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Epigenomics Molecular Diagnostics in Cancer Testing Product and Service

    • 14.9 bioTheranostics (AviaraDx)

      • 14.9.1 bioTheranostics (AviaraDx) Company Details

      • 14.9.2 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Product and Service

    • 14.10 Ambry Genetics

      • 14.10.1 Ambry Genetics Company Details

      • 14.10.2 Ambry Genetics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Product and Service

    • 14.11 Flatiron Health

      • 14.11.1 Flatiron Health Company Details

      • 14.11.2 Flatiron Health Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Flatiron Health Molecular Diagnostics in Cancer Testing Product and Service

    • 14.12 Genmark Diagnostics

      • 14.12.1 Genmark Diagnostics Company Details

      • 14.12.2 Genmark Diagnostics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Genmark Diagnostics Molecular Diagnostics in Cancer Testing Product and Service

    • 14.13 Abbott Molecular Diagnostics

      • 14.13.1 Abbott Molecular Diagnostics Company Details

      • 14.13.2 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Product and Service

    • 14.14 Neogenomics

      • 14.14.1 Neogenomics Company Details

      • 14.14.2 Neogenomics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Neogenomics Molecular Diagnostics in Cancer Testing Product and Service

    • 14.15 Genoptix (Novartis)

      • 14.15.1 Genoptix (Novartis) Company Details

      • 14.15.2 Genoptix (Novartis) Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Genoptix (Novartis) Molecular Diagnostics in Cancer Testing Product and Service

    • 14.16 Agendia

      • 14.16.1 Agendia Company Details

      • 14.16.2 Agendia Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Agendia Molecular Diagnostics in Cancer Testing Product and Service

    • 14.17 HTG Molecular Diagnostics

      • 14.17.1 HTG Molecular Diagnostics Company Details

      • 14.17.2 HTG Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 HTG Molecular Diagnostics Molecular Diagnostics in Cancer Testing Product and Service

    • 14.18 Biodesix

      • 14.18.1 Biodesix Company Details

      • 14.18.2 Biodesix Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Biodesix Molecular Diagnostics in Cancer Testing Product and Service

    • 14.19 Nanostring

      • 14.19.1 Nanostring Company Details

      • 14.19.2 Nanostring Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Nanostring Molecular Diagnostics in Cancer Testing Product and Service

    • 14.20 Accugenomics

      • 14.20.1 Accugenomics Company Details

      • 14.20.2 Accugenomics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Accugenomics Molecular Diagnostics in Cancer Testing Product and Service

    • 14.21 Pathway Genomics

      • 14.21.1 Pathway Genomics Company Details

      • 14.21.2 Pathway Genomics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Pathway Genomics Molecular Diagnostics in Cancer Testing Product and Service

    • 14.22 Orion Genomics

      • 14.22.1 Orion Genomics Company Details

      • 14.22.2 Orion Genomics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Orion Genomics Molecular Diagnostics in Cancer Testing Product and Service

    • 14.23 Myriad Genetics

      • 14.23.1 Myriad Genetics Company Details

      • 14.23.2 Myriad Genetics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Myriad Genetics Molecular Diagnostics in Cancer Testing Product and Service

    • 14.24 Exiqon

      • 14.24.1 Exiqon Company Details

      • 14.24.2 Exiqon Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 Exiqon Molecular Diagnostics in Cancer Testing Product and Service

    • 14.25 Nuvera Biosciences

      • 14.25.1 Nuvera Biosciences Company Details

      • 14.25.2 Nuvera Biosciences Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.25.3 Nuvera Biosciences Molecular Diagnostics in Cancer Testing Product and Service

    • 14.26 Genomic Health

      • 14.26.1 Genomic Health Company Details

      • 14.26.2 Genomic Health Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.26.3 Genomic Health Molecular Diagnostics in Cancer Testing Product and Service

    • 14.27 Cancer Genetics

      • 14.27.1 Cancer Genetics Company Details

      • 14.27.2 Cancer Genetics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.27.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Molecular Diagnostics in Cancer Testing

    • Figure Molecular Diagnostics in Cancer Testing Picture

    • Table Global Molecular Diagnostics in Cancer Testing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Molecular Diagnostics in Cancer Testing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Molecular Diagnostics in Cancer Testing Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Molecular Diagnostics in Cancer Testing Consumption by Country (2017-2022)

    • Figure United States Molecular Diagnostics in Cancer Testing Consumption and Growth Rate (2017-2022)

    • Table Europe Molecular Diagnostics in Cancer Testing Consumption and Growth Rate (2017-2022)

    • Figure China Molecular Diagnostics in Cancer Testing Consumption and Growth Rate (2017-2022)

    • Figure Japan Molecular Diagnostics in Cancer Testing Consumption and Growth Rate (2017-2022)

    • Figure India Molecular Diagnostics in Cancer Testing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Molecular Diagnostics in Cancer Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Molecular Diagnostics in Cancer Testing Consumption Forecast by Country (2022-2028)

    • Figure United States Molecular Diagnostics in Cancer Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Molecular Diagnostics in Cancer Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Molecular Diagnostics in Cancer Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Molecular Diagnostics in Cancer Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Molecular Diagnostics in Cancer Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Molecular Diagnostics in Cancer Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 3 Consumption and Growth Rate (2017-2022)

    • Figure Global Application 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Application 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Application 3 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 3 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Application 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Application 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Application 3 Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Molecular Diagnostics in Cancer Testing Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Molecular Diagnostics in Cancer Testing Export by Region (Top 5 Countries) (2017-2028)

    • Table LabCorp (Foundation Year, Company Profile and etc.)

    • Table LabCorp Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table LabCorp Molecular Diagnostics in Cancer Testing Product and Service

    • Table bioMerieux (Foundation Year, Company Profile and etc.)

    • Table bioMerieux Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table bioMerieux Molecular Diagnostics in Cancer Testing Product and Service

    • Table NSTG (Foundation Year, Company Profile and etc.)

    • Table NSTG Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table NSTG Molecular Diagnostics in Cancer Testing Product and Service

    • Table Invitae (Foundation Year, Company Profile and etc.)

    • Table Invitae Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Invitae Molecular Diagnostics in Cancer Testing Product and Service

    • Table Genomictree (Foundation Year, Company Profile and etc.)

    • Table Genomictree Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genomictree Molecular Diagnostics in Cancer Testing Product and Service

    • Table Exact Sciences Corporation (Foundation Year, Company Profile and etc.)

    • Table Exact Sciences Corporation Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Exact Sciences Corporation Molecular Diagnostics in Cancer Testing Product and Service

    • Table Counsyl (Foundation Year, Company Profile and etc.)

    • Table Counsyl Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Counsyl Molecular Diagnostics in Cancer Testing Product and Service

    • Table Epigenomics (Foundation Year, Company Profile and etc.)

    • Table Epigenomics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Epigenomics Molecular Diagnostics in Cancer Testing Product and Service

    • Table bioTheranostics (AviaraDx) (Foundation Year, Company Profile and etc.)

    • Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Product and Service

    • Table Ambry Genetics (Foundation Year, Company Profile and etc.)

    • Table Ambry Genetics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ambry Genetics Molecular Diagnostics in Cancer Testing Product and Service

    • Table Flatiron Health (Foundation Year, Company Profile and etc.)

    • Table Flatiron Health Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Flatiron Health Molecular Diagnostics in Cancer Testing Product and Service

    • Table Genmark Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Genmark Diagnostics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genmark Diagnostics Molecular Diagnostics in Cancer Testing Product and Service

    • Table Abbott Molecular Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Product and Service

    • Table Neogenomics (Foundation Year, Company Profile and etc.)

    • Table Neogenomics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neogenomics Molecular Diagnostics in Cancer Testing Product and Service

    • Table Genoptix (Novartis) (Foundation Year, Company Profile and etc.)

    • Table Genoptix (Novartis) Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genoptix (Novartis) Molecular Diagnostics in Cancer Testing Product and Service

    • Table Agendia (Foundation Year, Company Profile and etc.)

    • Table Agendia Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agendia Molecular Diagnostics in Cancer Testing Product and Service

    • Table HTG Molecular Diagnostics (Foundation Year, Company Profile and etc.)

    • Table HTG Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table HTG Molecular Diagnostics Molecular Diagnostics in Cancer Testing Product and Service

    • Table Biodesix (Foundation Year, Company Profile and etc.)

    • Table Biodesix Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biodesix Molecular Diagnostics in Cancer Testing Product and Service

    • Table Nanostring (Foundation Year, Company Profile and etc.)

    • Table Nanostring Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nanostring Molecular Diagnostics in Cancer Testing Product and Service

    • Table Accugenomics (Foundation Year, Company Profile and etc.)

    • Table Accugenomics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Accugenomics Molecular Diagnostics in Cancer Testing Product and Service

    • Table Pathway Genomics (Foundation Year, Company Profile and etc.)

    • Table Pathway Genomics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pathway Genomics Molecular Diagnostics in Cancer Testing Product and Service

    • Table Orion Genomics (Foundation Year, Company Profile and etc.)

    • Table Orion Genomics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orion Genomics Molecular Diagnostics in Cancer Testing Product and Service

    • Table Myriad Genetics (Foundation Year, Company Profile and etc.)

    • Table Myriad Genetics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myriad Genetics Molecular Diagnostics in Cancer Testing Product and Service

    • Table Exiqon (Foundation Year, Company Profile and etc.)

    • Table Exiqon Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Exiqon Molecular Diagnostics in Cancer Testing Product and Service

    • Table Nuvera Biosciences (Foundation Year, Company Profile and etc.)

    • Table Nuvera Biosciences Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nuvera Biosciences Molecular Diagnostics in Cancer Testing Product and Service

    • Table Genomic Health (Foundation Year, Company Profile and etc.)

    • Table Genomic Health Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genomic Health Molecular Diagnostics in Cancer Testing Product and Service

    • Table Cancer Genetics (Foundation Year, Company Profile and etc.)

    • Table Cancer Genetics Molecular Diagnostics in Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cancer Genetics Molecular Diagnostics in Cancer Testing Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US